MRNA Analyst Ratings

5 ratings from Wall Street analysts · Consensus as of Sep 1, 2026

Analyst Ratings

Hold Avg target $107 showing 5 ratings

Consensus is Hold with a $106.63 average target across 22 analysts (stockanalysis.com, as of 1 September 2026), on a range of $40 to $170. Rows below are recent sourced analyst actions. The range above is the consensus provider's. Individual analyst actions listed below are sourced separately and can fall outside it. Consensus as of Sep 1, 2026

MRNA

Upgrades

2026-08-28

Argus Research

RatingBuy

FromHold

Target$180

From—

Maintains

2026-08-24

Barclays

RatingHold

From—

Target$125

From$48

Maintains

2026-08-20

UBS

RatingHold

From—

Target$150

From$50

Maintains

2026-08-19

Morgan Stanley

RatingHold

From—

Target$89

From$39

Reiterates

2026-08-19

Jefferies

RatingHold

From—

Target$60

From—